BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 23275943)

  • 1. Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.
    Salem M; Seidelin JB; Rogler G; Nielsen OH
    Cell Mol Life Sci; 2013 Sep; 70(18):3391-404. PubMed ID: 23275943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species-specific engagement of human nucleotide oligomerization domain 2 (NOD)2 and Toll-like receptor (TLR) signalling upon intracellular bacterial infection: role of Crohn's associated NOD2 gene variants.
    Salem M; Seidelin JB; Eickhardt S; Alhede M; Rogler G; Nielsen OH
    Clin Exp Immunol; 2015 Mar; 179(3):426-34. PubMed ID: 25335775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.
    Girardin SE; Boneca IG; Viala J; Chamaillard M; Labigne A; Thomas G; Philpott DJ; Sansonetti PJ
    J Biol Chem; 2003 Mar; 278(11):8869-72. PubMed ID: 12527755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for impaired CARD15 signalling in Crohn's disease without disease linked variants.
    Seidelin JB; Broom OJ; Olsen J; Nielsen OH
    PLoS One; 2009 Nov; 4(11):e7794. PubMed ID: 19907652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease.
    van Heel DA; Ghosh S; Butler M; Hunt KA; Lundberg AM; Ahmad T; McGovern DP; Onnie C; Negoro K; Goldthorpe S; Foxwell BM; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Lancet; 2005 May 21-27; 365(9473):1794-6. PubMed ID: 15910952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.
    Inohara N; Ogura Y; Fontalba A; Gutierrez O; Pons F; Crespo J; Fukase K; Inamura S; Kusumoto S; Hashimoto M; Foster SJ; Moran AP; Fernandez-Luna JL; Nuñez G
    J Biol Chem; 2003 Feb; 278(8):5509-12. PubMed ID: 12514169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations.
    Li J; Moran T; Swanson E; Julian C; Harris J; Bonen DK; Hedl M; Nicolae DL; Abraham C; Cho JH
    Hum Mol Genet; 2004 Aug; 13(16):1715-25. PubMed ID: 15198989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired antibacterial autophagy links granulomatous intestinal inflammation in Niemann-Pick disease type C1 and XIAP deficiency with NOD2 variants in Crohn's disease.
    Schwerd T; Pandey S; Yang HT; Bagola K; Jameson E; Jung J; Lachmann RH; Shah N; Patel SY; Booth C; Runz H; Düker G; Bettels R; Rohrbach M; Kugathasan S; Chapel H; Keshav S; Elkadri A; Platt N; Muise AM; Koletzko S; Xavier RJ; Marquardt T; Powrie F; Wraith JE; Gyrd-Hansen M; Platt FM; Uhlig HH
    Gut; 2017 Jun; 66(6):1060-1073. PubMed ID: 26953272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi screening identifies mediators of NOD2 signaling: implications for spatial specificity of MDP recognition.
    Lipinski S; Grabe N; Jacobs G; Billmann-Born S; Till A; Häsler R; Aden K; Paulsen M; Arlt A; Kraemer L; Hagemann N; Erdmann KS; Schreiber S; Rosenstiel P
    Proc Natl Acad Sci U S A; 2012 Dec; 109(52):21426-31. PubMed ID: 23213202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engagement of NOD2 has a dual effect on proIL-1beta mRNA transcription and secretion of bioactive IL-1beta.
    Ferwerda G; Kramer M; de Jong D; Piccini A; Joosten LA; Devesaginer I; Girardin SE; Adema GJ; van der Meer JW; Kullberg BJ; Rubartelli A; Netea MG
    Eur J Immunol; 2008 Jan; 38(1):184-91. PubMed ID: 18157816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD2 modulates immune tolerance via the GM-CSF-dependent generation of CD103
    Prescott D; Maisonneuve C; Yadav J; Rubino SJ; Girardin SE; Philpott DJ
    Proc Natl Acad Sci U S A; 2020 May; 117(20):10946-10957. PubMed ID: 32350141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperexpression of NOD2 in intestinal mast cells of Crohn's disease patients: preferential expression of inflammatory cell-recruiting molecules via NOD2 in mast cells.
    Okumura S; Yuki K; Kobayashi R; Okamura S; Ohmori K; Saito H; Ra C; Okayama Y
    Clin Immunol; 2009 Feb; 130(2):175-85. PubMed ID: 18938111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
    van Heel DA; Ghosh S; Hunt KA; Mathew CG; Forbes A; Jewell DP; Playford RJ
    Gut; 2005 Nov; 54(11):1553-7. PubMed ID: 15928043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
    Mo J; Boyle JP; Howard CB; Monie TP; Davis BK; Duncan JA
    J Biol Chem; 2012 Jun; 287(27):23057-67. PubMed ID: 22549783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.
    Hedl M; Abraham C
    J Biol Chem; 2011 Jul; 286(30):26440-9. PubMed ID: 21659536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptidoglycan Metabolite Photoaffinity Reporters Reveal Direct Binding to Intracellular Pattern Recognition Receptors and Arf GTPases.
    Wang YC; Westcott NP; Griffin ME; Hang HC
    ACS Chem Biol; 2019 Mar; 14(3):405-414. PubMed ID: 30735346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a synthetic muramyl peptide derivative with enhanced Nod2 stimulatory capacity.
    Rubino SJ; Magalhaes JG; Philpott D; Bahr GM; Blanot D; Girardin SE
    Innate Immun; 2013 Oct; 19(5):493-503. PubMed ID: 23339926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Muramyl Dipeptide-Dependent NOD2 Activity by a Self-Derived Peptide.
    Mann JK; Shen J; Park S
    J Cell Biochem; 2017 May; 118(5):1227-1238. PubMed ID: 27791288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.